Neptune Technologies & Bioressources Inc.

Neptune Technologies & Bioressources Inc. in connection with closing US$34 million transaction with Aker Biomarine Antarctic AS to accelerate business and industry development

Client

Neptune Technologies & Bioressources Inc.

Value

US$34 million

Service

Mergers and Acquisitions

Date Closed

August 2017

Industry

Pharmaceuticals and Life Sciences

Lead Office

Montréal

 

On August 8, 2017, Aker Biomarine Antarctic AS (“Aker”) announced its acquisition of Neptune Technologies & Bioressources krill inventory and intellectual property for US$34 million. The acquisition will be used to accelerate business and industry development.

Aker is a Norwegian based biotechnology and krill-harvesting company that develops, markets, and sells krill-based ingredients for nutraceutical, aquaculture, and animal feed applications.

Neptune Technologies & Bioressources is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America.

Osler, Hoskin & Harcourt LLP represented Neptune Technologies & Bioressources with a team consisting of François Paradis, Mikulas Arendas and Tim Apedaile (Corporate).